Your browser doesn't support javascript.
loading
Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens.
Agarwal, Sanjeev; Hickey, John M; Sahni, Neha; Toth, Ronald T; Robertson, George A; Sitrin, Robert; Cryz, Stanley; Joshi, Sangeeta B; Volkin, David B.
Afiliação
  • Agarwal S; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas 66047.
  • Hickey JM; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas 66047.
  • Sahni N; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas 66047.
  • Toth RT; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas 66047.
  • Robertson GA; The Center for Vaccine Innovation and Access, PATH, Washington, District of Columbia 20001.
  • Sitrin R; The Center for Vaccine Innovation and Access, PATH, Washington, District of Columbia 20001.
  • Cryz S; The Center for Vaccine Innovation and Access, PATH, Washington, District of Columbia 20001.
  • Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas 66047.
  • Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas 66047. Electronic address: volkin@ku.edu.
J Pharm Sci ; 109(1): 380-393, 2020 01.
Article em En | MEDLINE | ID: mdl-31400347

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Rotavirus / Rotavirus / Vacinas contra Rotavirus / Antígenos Virais Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Rotavirus / Rotavirus / Vacinas contra Rotavirus / Antígenos Virais Idioma: En Ano de publicação: 2020 Tipo de documento: Article